ANGPTL6 Kit ELISA
-
- Antigène Voir toutes ANGPTL6 Kits ELISA
- ANGPTL6 (Angiopoietin-Like 6 (ANGPTL6))
-
Reactivité
- Humain
- Méthode de détection
- Colorimetric
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 1.56-100 ng/mL
- Seuil minimal de détection
- 1.56 ng/mL
- Application
- ELISA
- Type d'échantillon
- Cell Culture Supernatant, Plasma, Serum
- Analytical Method
- Quantitative
- Specificité
- Detects human ANGPTL6.
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Does not cross-react with human ANGPTL3, human ANGPTL4 or human ANGPTL7.
- Sensibilité
- 1.2 ng/mL
- Attributs du produit
- ANGPTL6 (human) ELISA Kit
- Featured
- Discover our best selling ANGPTL6 Kit ELISA
- Top Product
- Discover our top product ANGPTL6 Kit ELISA
-
-
- Plaque
- Pre-coated
- Restrictions
- For Research Use only
-
- Stock
- 4 °C
- Stockage commentaire
-
Short Term Storage: +4°C
Long Term Storage: +4°C
-
- Antigène Voir toutes ANGPTL6 Kits ELISA
- ANGPTL6 (Angiopoietin-Like 6 (ANGPTL6))
- Autre désignation
- ANGPTL6 (ANGPTL6 Produits)
- Synonymes
- AGF Kit ELISA, ARP5 Kit ELISA, 6330404E11Rik Kit ELISA, ARP3 Kit ELISA, Arp5 Kit ELISA, cb242 Kit ELISA, sb:cb242 Kit ELISA, ACTR3 Kit ELISA, angiopoietin like 6 Kit ELISA, angiopoietin-like 6 Kit ELISA, ARP3 actin related protein 3 homolog Kit ELISA, ANGPTL6 Kit ELISA, Angptl6 Kit ELISA, angptl6 Kit ELISA, ACTR3 Kit ELISA
- Sujet
- Seven proteins containing an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain, both characteristics of angiopoietins, have been identified and therefore designated angiopoietin-like proteins 1-7 (ANGPTL 1-7). ANGPTL3 and ANGPTL6 (Angiopoietin-related growth factor, AGF), among others, function to regulate angiogenesis and also appear to directly regulate lipid, glucose and energy metabolism. The serum levels of ANGPTL6 are significantly increased in obese humans, patients with type 2 diabetes mellitus (T2DM) and in metabolic syndrome. Therefore, ANGPTL6 may be a novel biomarker for metabolic diseases and may provide a novel therapeutic approach to counteract obesity, T2DM and insulin resistance.
- UniProt
- Q8NI99
- Pathways
- Regulation of Actin Filament Polymerization
-